Haemophilia trials in United Kingdom

In United Kingdom 18 Also abroad 128

18 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
The CACHE Study: Coronary Artery Care in HaEmophilia
Where
Oxford
Age
45 years to 120 years
People
80
Run by
Oxford University Hospitals NHS Trust
See details and how to joinNCT06706206
Phase 3Taking people
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Where
Cardiff, London
Age
12 years and over
People
360 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00
Phase 3Taking people
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Where
Birmingham, Cardiff, London, Oxford, Sheffield
Age
18 years and over
People
84 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07830732 · EU 2026-525529-19-00
Phase 3Taking people
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Where
Birmingham, London, Newcastle upon Tyne
Age
1 year to 74 years
People
245 worldwide
Run by
Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Where
Cardiff, London, Oxford
Age
12 years and over
People
138 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00
Phase 1/2Taking people
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Where
Birmingham, Cambridge, Glasgow, London, Oxford
Age
2 years and over
People
130 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06379789 · EU 2023-507260-40-00
Phase 3Taking people
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
Where
London, Oxford
Age
138 months to 206 months
People
20 worldwide
Run by
CSL Behring
See details and how to joinNCT07080905 · EU 2023-505805-18-00
Phase 3Taking people
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Where
Birmingham, London, Manchester, Newcastle upon Tyne
Age
1 year to 17 years
People
100 worldwide
Run by
Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00
No phaseEnrolling by invitation
Adverse Event Data Collection From External Registries on Nonacog Beta Pegol
Where
Sheffield
People
10 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT03690336
Phase 1Taking people
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Where
Birmingham, London, Sheffield
Age
18 years to 64 years
People
30 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07220564 · EU 2025-520490-38-00
No phaseEnrolling by invitation
A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
Where
Aberdeen, Cardiff, Manchester, Sheffield
People
60 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT03745924
No phaseTaking people
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Where
Birmingham, Headington, London, Newcastle upon Tyne
People
200 worldwide
Run by
Octapharma
See details and how to joinNCT03695978
Phase 4Taking people
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Where
Leeds
Age
12 years and over
People
28 worldwide
Run by
Octapharma
See details and how to joinNCT05935358
Phase 4Taking people
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Where
Leeds
Age
12 years and over
People
28 worldwide
Run by
Octapharma
See details and how to joinNCT05936580
Phase 4Enrolling by invitation
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
Where
Cambridge, Glasgow, London, Oxford, Southampton
Age
18 years and over
People
172 worldwide
Run by
BioMarin Pharmaceutical
See details and how to joinNCT05768386 · EU 2023-507749-27-00
No phaseTaking people
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Where
Birmingham, Edinburgh, Glasgow, London
People
4,000 worldwide
Run by
PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119
Phase 2/3Enrolling by invitation
Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
Where
Cambridge, London, Southampton
Age
18 years and over
People
56 worldwide
Run by
CSL Behring
See details and how to joinNCT05962398 · EU 2023-503765-37-00
No phaseTaking people
Liver Biopsy In Haemophilia Gene Therapy
Where
London
Age
18 years to 80 years
People
10
Run by
University College, London
See details and how to joinNCT04817462